PBI
53
4
SWK
52
-6
APA
48
-5
NI
65
-2
KR
29
-3
MMM
54
-3
MRK
56
-4
CVX
23
-2
PCG
67
-2
MOS
26
-12
LB
22
-7
BAX
50
-3
ED
42
-3
GS
72
-3
L
65
-4
NAVI
40
5
EW
57
7
KMI
53
-6
AEE
53
-5
DUK
52
-2
PBI
53
4
SWK
52
-6
APA
48
-5
NI
65
-2
KR
29
-3
MMM
54
-3
MRK
56
-4
CVX
23
-2
PCG
67
-2
MOS
26
-12
LB
22
-7
BAX
50
-3
ED
42
-3
GS
72
-3
L
65
-4
NAVI
40
5
EW
57
7
KMI
53
-6
AEE
53
-5
DUK
52
-2
Financhill
Back

Nuveen Credit Strategies Income Fund Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Buy
59

JQC
Nuveen Credit Strategies Income Fund

Last Price:
$4.99
Seasonality Move:
0.94%
Sell
45

ZBIO
Zenas BioPharma, Inc.

Last Price:
$36.38
Seasonality Move:
-8.13%
Buy
59
Nuveen Credit Strategies Income Fund (JQC) is a Buy

Is Nuveen Credit Strategies Income Fund a Buy, Sell or Hold?

  • The current Nuveen Credit Strategies Income Fund [JQC] share price is $5.00. The Score for JQC is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • JQC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $36.89. The Score for ZBIO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JQC Stock Price Chart

What is Nuveen Credit Strategies Income Fund's stock price today?

  • The Nuveen Credit Strategies Income Fund share price today is $5.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JQC is experiencing slight buying pressure.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $36.89
    The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

JQC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 38.68 Sell
Chaikin Money Flow: 242453 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 51.69 Buy
Chaikin Money Flow: 321584 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

JQC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.04 Sell
20-day SMA: 5.04 Sell
50-day SMA: 5.08 Sell
200-day SMA: 5.29 Sell
8-day EMA: 5.04 Sell
20-day EMA: 5.05 Sell
50-day EMA: 5.11 Sell
200-day EMA: 5.3 Sell

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.29 Sell
20-day SMA: 37.71 Sell
50-day SMA: 32.54 Buy
200-day SMA: 17.6 Buy
8-day EMA: 37.45 Sell
20-day EMA: 34.56 Buy
50-day EMA: 23.69 Buy
200-day EMA: 8.26 Buy

Nuveen Credit Strategies Income Fund Earnings Growth & JQC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

Nuveen Credit Strategies Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):